Janux Therapeutics Inc. (JANX)

NASDAQ: JANX · Real-Time Price · USD

32.10

-1.10 (-3.31%)

At close: May 01, 2025, 3:59 PM

32.80

2.16%

Pre-market: May 02, 2025, 06:39 AM EDT

Janux Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-68.99M	-58.29M	-63.06M	-32.67M	-6.78M	-4M
Depreciation & Amortization	2.06M	1.96M	841K	113K	13K	6K
Stock-Based Compensation	33.02M	20M	17.2M	6.91M	72K	6K
Other Working Capital	-899K	-6.83M	4.57M	-2.13M	8M	-73K
Other Non-Cash Items	-10.59M	-7.69M	-2.18M	-169K	1.94M	233K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	685K	-6.55M	4.28M	8.84M	389K	-69K
Operating Cash Flow	-43.81M	-50.58M	-42.92M	-16.98M	-4.37M	-3.83M
Capital Expenditures	-359K	-1.85M	-6.45M	-1.48M	n/a	n/a
Cash Acquisitions	n/a	n/a	-64.71M	339.48M	n/a	n/a
Purchase of Investments	-470.58M	-317.34M	-294.39M	-473.63M	n/a	n/a
Sales Maturities Of Investments	212.91M	278M	359.1M	134.15M	n/a	n/a
Other Investing Acitivies	n/a	n/a	64.71M	-339.48M	n/a	n/a
Investing Cash Flow	-258.02M	-41.19M	58.27M	-340.96M	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	2.5M	4M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	14.97M	3.02M	500K	1.81M	9.02M	n/a
Financial Cash Flow	713.24M	59.55M	500K	386.52M	11.52M	4M
Net Cash Flow	411.4M	-32.22M	15.84M	28.59M	7.16M	172K
Free Cash Flow	-44.17M	-52.42M	-49.37M	-18.46M	-4.37M	-3.83M